FNT
MDGL icon

First National Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

First National Trust’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,476
Closed -$1.14M – 412
2025
Q3 		$1.14M Sell
2,476
-5,538
-69% -$2.07M 0.04% 231
2025
Q2 		$2.43M Hold
8,014
– – 0.09% 168
2025
Q1 		$2.65M Buy
8,014
+4,470
+126% +$1.47M 0.11% 157
2024
Q4 		$1.09M Hold
3,544
– – 0.04% 229
2024
Q3 		$752K Hold
3,544
– – 0.03% 254
2024
Q2 		$993K Hold
3,544
– – 0.04% 220
2024
Q1 		$946K Sell
3,544
-870
-20% -$205K 0.04% 222
2023
Q4 		$1.02M Sell
4,414
-455
-9% -$79.6K 0.04% 206
2023
Q3 		$711K Hold
4,869
– – 0.03% 235
2023
Q2 		$1.12M Hold
4,869
– – 0.05% 190
2023
Q1 		$1.18M Buy
+4,869
New +$1.33M 0.06% 178

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return